Longevity Health (XAGE) Revenue & Revenue Breakdown
Longevity Health Revenue Highlights
0
Latest Revenue (Q)
$20.52K
Longevity Health Revenue by Period
Longevity Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | - |
Longevity Health generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Longevity Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $20.52K | 66.55% |
| 2024-06-30 | $12.32K | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-3.73M | -200.00% |
| 2023-09-30 | $3.73M | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | - |
Longevity Health generated $20.52K in revenue during Q3 2024, up 66.55% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Longevity Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CCM | Concord Medical Services | $537.40M | $34.94M |
| ADTX | Aditxt | $133.99M | $1.02K |
| CELU | Celularity | $22.77M | $18.13M |
| SISI | Shineco | $9.80M | $40.97K |
| SYRA | Syra Health Corp. Class A | $7.98M | $1.86M |
| ZVSA | ZyVersa Therapeutics | - | - |
| XAGE | Longevity Health | - | $20.52K |
| SCNI | Scinai Immunotherapeutics | - | - |
| LIXT | Lixte Biotechnology | - | - |